Option Care Health, Inc.OPCHNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor OPCH?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor OPCH

Key Statistics

About

as of august 7, 2019, option care and bioscrip have merged to become one national team, solely dedicated to infusion care. option care health, inc. is the largest independent home and alternate site infusion services provider in the united states.

Sector

Health Care and Social Assistance

Industry

Home Health Care Services

CEO

John Rademacher

optioncarehealth.com/ →

News

IBM exec says Trump's Fed pick will 'overhaul' central bank policies while bringing crisis expertise

foxbusiness.com

CPNG Investors Have Opportunity to Lead Coupang, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

prnewswire.com

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Signs a Stock Purchase Agreement for the Sale of $10 Million of Its Class A Common Stock to a Designated Third Party Identified by AIxC

businesswire.com

Bitcoin's Fall, Why Now Is The Time For A Contrarian-Long IBIT Play

seekingalpha.com

Nvidia's OpenAI investment may not be as big as once hoped, adding to a jittery tech trade

marketwatch.com

Top 15 High-Growth Dividend Stocks For February 2026

seekingalpha.com

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

prnewswire.com

Is It Time to Take a Bite Out of Apple's Stock as Revenue Growth Accelerates?

fool.com

Is This CLO-Focused Fixed Income ETF a Buy After O'Donnell Financial Bought Shares Worth $6.8 Million?

fool.com

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

seekingalpha.com

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

accessnewswire.com

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

newsfilecorp.com

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

seekingalpha.com

3 Reasons to Buy Uber Stock Like There's No Tomorrow

fool.com

Apple Loses More AI Researchers to Meta and Google

pymnts.com

A March Decision That Could Change Protalix BioTherapeutics Outlook

seekingalpha.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

NetDragon Leads Government-Backed AI Push to Build Thailand's Future Workforce

Buy Zoom And Get Anthropic Equity Now Before The IPO

ING Groep: Executing Well, But No Longer Undervalued (Rating Downgrade)

BlueScope Steel Open to Better Offers After Spurning $8.8 Billion Takeover Bid

IBM exec says Trump's Fed pick will 'overhaul' central bank policies while bringing crisis expertise

CPNG Investors Have Opportunity to Lead Coupang, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Signs a Stock Purchase Agreement for the Sale of $10 Million of Its Class A Common Stock to a Designated Third Party Identified by AIxC

Bitcoin's Fall, Why Now Is The Time For A Contrarian-Long IBIT Play

Nvidia's OpenAI investment may not be as big as once hoped, adding to a jittery tech trade

Top 15 High-Growth Dividend Stocks For February 2026

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

Is It Time to Take a Bite Out of Apple's Stock as Revenue Growth Accelerates?

Is This CLO-Focused Fixed Income ETF a Buy After O'Donnell Financial Bought Shares Worth $6.8 Million?

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

3 Reasons to Buy Uber Stock Like There's No Tomorrow

Apple Loses More AI Researchers to Meta and Google

A March Decision That Could Change Protalix BioTherapeutics Outlook

Explore More

NetDragon Leads Government-Backed AI Push to Build Thailand's Future Workforce

Buy Zoom And Get Anthropic Equity Now Before The IPO

ING Groep: Executing Well, But No Longer Undervalued (Rating Downgrade)

BlueScope Steel Open to Better Offers After Spurning $8.8 Billion Takeover Bid

IBM exec says Trump's Fed pick will 'overhaul' central bank policies while bringing crisis expertise

CPNG Investors Have Opportunity to Lead Coupang, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Signs a Stock Purchase Agreement for the Sale of $10 Million of Its Class A Common Stock to a Designated Third Party Identified by AIxC

Bitcoin's Fall, Why Now Is The Time For A Contrarian-Long IBIT Play

Nvidia's OpenAI investment may not be as big as once hoped, adding to a jittery tech trade

Top 15 High-Growth Dividend Stocks For February 2026

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

Is It Time to Take a Bite Out of Apple's Stock as Revenue Growth Accelerates?

Is This CLO-Focused Fixed Income ETF a Buy After O'Donnell Financial Bought Shares Worth $6.8 Million?

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

3 Reasons to Buy Uber Stock Like There's No Tomorrow

Apple Loses More AI Researchers to Meta and Google

A March Decision That Could Change Protalix BioTherapeutics Outlook

Key Statistics